In this first Pointellis episode, Adlai Goldberg speaks with Asaf Adler, Operations Senior Manager with EY, about his emotional journey from stage 4 melanoma to full remission.
Asaf Adler faced among the hardest patient challenges imaginable: stage 4 melanoma and lung cancer. But, today, as a cancer survivor, he’s optimistic about the state of cancer treatments. In this podcast, Adlai Goldberg, EY Social and Commercial Innovation Life Sciences Leader, speaks with Asaf, EY Americas Senior Manager Consulting, Business Consulting, Supply Chain & Operations, about his experience finding out he had cancer to his discovery of individual-targeted treatments, his journey to remission and overall advancements in the life science sector.
Summer 2021 is a milestone in cancer treatment, as Phase 2 of the mRNA cancer vaccine (BioNTech) is introduced to its first patient. Asaf and Adlai share their excitement and hope around this amazing era of hope for cancer treatment.
Learning outcomes
Asaf’s own remarkable story underscores how quickly the clinical science is advancing and the profound impact these treatments have not only on the lives of current patients, but also to the loved ones surrounding them.
For your convenience, full text transcript of this podcast is also available. Read the transcript.
Presenters
Adlai Goldberg
EY Global Digital, Social and Commercial Innovation Life Sciences Leader
Asaf Adler
EY Americas Senior Manager Consulting, Business Consulting, Supply Chain & OperationsPodcast
Episode 02
Duration 17m 15s
In this series
Series overviewThe promise of advanced therapies: the patient experience
Episode 02
Presenters
The age of ‘Health Experience’
Episode 01
